Cationic liposome-based mRNA delivery system for COVID-19 vaccines and osteoarthritis treatment

1. Proprietary mRNA delivery system, EG-R, composed of a cationic lipid and helper lipids: No PEG & No side effects, enhances stability & target expression.

2. Stable freeze-dried mRNA vaccines more than 24 months under refrigerated conditions (2-8^oC).

3. Phase 1/2a clinical trial of EG-COVID (WT) and EG-COVARo (Omicron) in Australia as a booster vaccination.

4. Confirmation of the regenerative effect of cartilage components in a mouse cartilage damage model with candidate mRNA therapeutics.